Clicky

WuXi AppTec Co Ltd H(2359)

Description: WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.


Keywords: Life Sciences Drug Discovery Drug Development Wuxi Contract Research Organizations Clinical Research Services Wuxi Apptec Drug Discovery Services Wuxi Biologics Pharmaceutical And Biotech Customers Biology Services Medical Device Testing Services

Home Page: www.wuxiapptec.com

288 Fute Zhong Road
Shanghai, 200131
China
Phone: 86 21 5046 1111


Officers

Name Title
Dr. Ge Li Ph.D. Co-Founder, Chairman, Pres & CEO
Dr. Minzhang Chen Ph.D. Co-Chief Exec. Officer & Exec. Director
Dr. Qing Yang Ph.D. Co-CEO & Exec. Director
Dr. Edward Hu M.B.A. Vice Chairman & Global Chief Investment Officer
Ms. Ming Shi Sr. VP & CFO
Dr. Shuhui Chen Ph.D. Chief Scientific Officer & Exec. VP
Mr. Kyler Lei IR Director
Mr. Yao Chi Joint Company Sec. & Exec. Director of the Corp. Legal Office
Dr. Howard Wu J.D. Sr. VP, Gen. Counsel & Global Head of HR
Mr. Zhaohui Zhang COO of China, Exec. VP & Director

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 19.4175
Trailing PE: 30.3241
Price-to-Book MRQ: 4.5375
Price-to-Sales TTM: 7.4399
IPO Date:
Fiscal Year End: December
Full Time Employees: 45646
Back to stocks